Myriad Genetics, Inc. (MYGN): Price and Financial Metrics
MYGN Price/Volume Stats
| Current price | $13.36 | 52-week high | $29.30 |
| Prev. close | $13.17 | 52-week low | $12.87 |
| Day low | $13.04 | Volume | 3,971,700 |
| Day high | $13.56 | Avg. volume | 772,582 |
| 50-day MA | $17.86 | Dividend yield | N/A |
| 200-day MA | $22.71 | Market Cap | 1.22B |
MYGN Stock Price Chart Interactive Chart >
Myriad Genetics, Inc. (MYGN) Company Bio
Myriad Genetics discovers and commercializes molecular diagnostic tests that; determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties to improve patient care. The company was founded in 1991 and is based in Salt Lake City, Utah.
MYGN Price Returns
| 1-mo | -11.64% |
| 3-mo | -51.66% |
| 6-mo | -45.51% |
| 1-year | -34.19% |
| 3-year | -50.57% |
| 5-year | -46.14% |
| YTD | -30.20% |
| 2023 | 31.91% |
| 2022 | -47.43% |
| 2021 | 39.57% |
| 2020 | -27.38% |
| 2019 | -6.33% |
Continue Researching MYGN
Want to do more research on Myriad Genetics Inc's stock and its price? Try the links below:Myriad Genetics Inc (MYGN) Stock Price | Nasdaq
Myriad Genetics Inc (MYGN) Stock Quote, History and News - Yahoo Finance
Myriad Genetics Inc (MYGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...